Mechanical properties and biocompatibility of a novel miniscrew made of Zr70Ni16Cu6Al8 bulk metallic glass for orthodontic anchorage.

The purpose of the present study was to fabricate a miniscrew possible for clinical application using Zr70Ni16Cu6Al8 bulk metallic glass (BMG), which has high mechanical strength, low elastic modulus, and high biocompatibility. First, the elastic moduli of Zr-based metallic glass rods made of Zr55Ni5Cu30Al10, Zr60Ni10Cu20Al10, Zr65Ni10Cu17.5Al7.5, Zr68Ni12Cu12Al8, and Zr70Ni16Cu6Al8 were measured. Zr70Ni16Cu6Al8 had the lowest elastic modulus among them. Then, we fabricated Zr70Ni16Cu6Al8 BMG miniscrews with diameters from 0.9 to 1.3 mm, conducted a torsion test, and implanted them into the alveolar bone of beagle dogs to compare insertion torque, removal torque, Periotest, new bone formation around the miniscrew, and failure rate compared with 1.3 mm diameter Ti-6Al-4 V miniscrew. The Zr70Ni16Cu6Al8 BMG miniscrew exhibited a high torsion torque even if the miniscrew had a small diameter. Zr70Ni16Cu6Al8 BMG miniscrews with a diameter of 1.1 mm or less had higher stability and lower failure rate than 1.3 mm diameter Ti-6Al-4 V miniscrews. Furthermore, the smaller diameter Zr70Ni16Cu6Al8 BMG miniscrew was shown, for the first time, to have a higher success rate and to form more new bone around the miniscrew. These findings suggested the usefulness of our novel small miniscrew made of Zr70Ni16Cu6Al8 BMG for orthodontic anchorage.

G364R mutation of MCM4 detected in human skin cancer cells affects DNA helicase activity of MCM4/6/7 complex.

A number of gene mutations are detected in cells derived from human cancer tissues, but roles of these mutations in cancer cell development are largely unknown. We examined G364R mutation of MCM4 detected in human skin cancer cells. Formation of MCM4/6/7 complex is not affected by the mutation. Consistent with this notion, the binding to MCM6 is comparable between the mutant MCM4 and wild-type MCM4. Nuclear localization of this mutant MCM4 expressed in HeLa cells supports this conclusion. Purified MCM4/6/7 complex containing the G364R MCM4 exhibited similar levels of single-stranded DNA binding and ATPase activities to the complex containing wild-type MCM4. However, the mutant complex showed only 30-50% of DNA helicase activity of the wild-type complex. When G364R MCM4 was expressed in HeLa cells, it was fractionated into nuclease-sensitive chromatin fraction, similar to wild-type MCM4. These results suggest that this mutation does not affect assembly of MCM2-7 complex on replication origins but it interferes some step at function of MCM2-7 helicase. Thus, this mutation may contribute to cancer cell development by disturbing DNA replication.